This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, July 21, 2017
Perspective for those who want to dig deeper on prescription drug costs
Perspective for those who want to dig deeper on prescription drug costs
By Scott Scanlon
There are many threads to pull when it comes to determining why prescription drugs cost as much as they do – and how they can be made more affordable for the governments and billions of people who depend on them, at least in part, for their health and wellness. I looked to hit the high points with the main story in this week's Refresh coverage, but found several other stories and sources worth noting for readers who want more context and the opportunity to dig deeper.
On This Blog The controversy over expensive new drugs for hepatitis C Link to research and news articles addressing the high cost of hepatitis C drugs; insurance restrictions - private insurers/Medicaid - and availability of generic versions/India, Egypt and other lower-income countries or through online "buyers clubs"
No comments:
Post a Comment